Effects of Angiotensin Converting Enzyme Inhibitor and Angiotensin II Receptor Antagonist Combination on Nitric Oxide Bioavailability and Atherosclerotic Change in Watanabe Heritable Hyperlipidemic Rabbits

Hypertension Research ◽

10.1291/hypres.31.575 ◽

2008 ◽

Vol 31 (3) ◽

pp. 575-584 ◽

Author(s):

Toshio IMANISHI ◽

Akio KUROI ◽

Hideyuki IKEJIMA ◽

Katsunobu KOBAYASHI ◽

Yasuteru MURAGAKI ◽

...

Keyword(s):

Nitric Oxide ◽

Angiotensin Ii ◽

Angiotensin Converting Enzyme ◽

Receptor Antagonist ◽

Enzyme Inhibitor ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Angiotensin Ii Receptor Antagonist ◽

Atherosclerotic Change ◽

Nitric Oxide Bioavailability

Download Full-text

Combined Effects of an 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor and Angiotensin II Receptor Antagonist on Nitric Oxide Bioavailability and Atherosclerotic Change in Myocardial Infarction-Prone Watanabe Heritable Hyperlipidemic Rabbits

Hypertension Research ◽

10.1291/hypres.31.1199 ◽

2008 ◽

Vol 31 (6) ◽

pp. 1199-1208 ◽

Author(s):

Toshio IMANISHI ◽

Hideyuki IKEJIMA ◽

Atsushi TSUJIOKA ◽

Akio KUROI ◽

Katsunobu KOBAYASHI ◽

...

Keyword(s):

Nitric Oxide ◽

Myocardial Infarction ◽

Angiotensin Ii ◽

Receptor Antagonist ◽

Reductase Inhibitor ◽

Combined Effects ◽

Angiotensin Ii Receptor ◽

Angiotensin Ii Receptor Antagonist ◽

Atherosclerotic Change ◽

Nitric Oxide Bioavailability

Download Full-text

Renal and Cardiovascular Effects of Angiotensin-Converting Enzyme Inhibitor Plus Angiotensin II Receptor Antagonist Therapy in Children With Proteinuria

10.1542/peds.2005-2053 ◽

2006 ◽

Vol 118 (3) ◽

pp. e833-e838 ◽

Author(s):

R. Lubrano ◽

F. Soscia ◽

M. Elli ◽

F. Ventriglia ◽

C. Raggi ◽

...

Keyword(s):

Angiotensin Ii ◽

Angiotensin Converting Enzyme ◽

Receptor Antagonist ◽

Angiotensin Converting Enzyme Inhibitor ◽

Enzyme Inhibitor ◽

Cardiovascular Effects ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Angiotensin Ii Receptor Antagonist ◽

Antagonist Therapy

Download Full-text

Comparison of the influence of angiotensin-converting enzyme inhibitor lisinopril and angiotensin II receptor antagonist losartan in patients with idiopathic membranous nephropathy and nephrotic syndrome

Scandinavian Journal of Urology and Nephrology ◽

10.3109/00365591003667351 ◽

2010 ◽

Vol 44 (4) ◽

pp. 251-256 ◽

Author(s):

George Kosmadakis ◽

Vasileios Filiopoulos ◽

Christodoulos Georgoulias ◽

Nicolaos Tentolouris ◽

Spiridon Michail

Keyword(s):

Nephrotic Syndrome ◽

Angiotensin Ii ◽

Angiotensin Converting Enzyme ◽

Receptor Antagonist ◽

Angiotensin Converting Enzyme Inhibitor ◽

Membranous Nephropathy ◽

Enzyme Inhibitor ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Angiotensin Ii Receptor Antagonist

Download Full-text

Effects of treatment with angiotensin-converting enzyme inhibitor (ACEI) or angiotensin II receptor antagonist (AIIRA) on renal function and glomerular injury in subtotal nephrectomized rats

Journal of Clinical Laboratory Analysis ◽

10.1002/(sici)1098-2825(1997)11:1<53::aid-jcla9>3.0.co;2-l ◽

1997 ◽

Vol 11 (1) ◽

pp. 53-62 ◽

Author(s):

Masatoshi Yamamoto ◽

Mitsumine Fukui ◽

Ichiyu Shou ◽

Li Ning Wang ◽

Keiko Sekizuka ◽

...

Keyword(s):

Renal Function ◽

Angiotensin Ii ◽

Angiotensin Converting Enzyme ◽

Receptor Antagonist ◽

Angiotensin Converting Enzyme Inhibitor ◽

Enzyme Inhibitor ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Glomerular Injury ◽

Angiotensin Ii Receptor Antagonist

Download Full-text

Vol. 31 (2008) 1199–1208 Erratum to: Combined Effects of an 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor and Angiotensin II Receptor Antagonist on Nitric Oxide Bioavailability and Atherosclerotic Change in Myocardial Infarction–Prone Watanabe Heritable Hyperlipidemic Rabbits

Hypertension Research ◽

10.1291/hypres.31.1677 ◽

2008 ◽

Vol 31 (8) ◽

pp. 1677

Keyword(s):

Nitric Oxide ◽

Myocardial Infarction ◽

Angiotensin Ii ◽

Receptor Antagonist ◽

Reductase Inhibitor ◽

Combined Effects ◽

Angiotensin Ii Receptor ◽

Angiotensin Ii Receptor Antagonist ◽

Atherosclerotic Change ◽

Nitric Oxide Bioavailability

Download Full-text

Effects of Angiotensin-Converting Enzyme Inhibitor, Angiotensin II Receptor Antagonist and Calcium Antagonist on Urinary Podocytes in Patients with IgA Nephropathy

American Journal of Nephrology ◽

10.1159/000013619 ◽

2000 ◽

Vol 20 (5) ◽

pp. 373-379 ◽

Author(s):

Tsukasa Nakamura ◽

Chifuyu Ushiyama ◽

Shingo Suzuki ◽

Masanori Hara ◽

Noriaki Shimada ◽

...

Keyword(s):

Calcium Antagonist ◽

Angiotensin Ii ◽

Angiotensin Converting Enzyme ◽

Receptor Antagonist ◽

Iga Nephropathy ◽

Angiotensin Converting Enzyme Inhibitor ◽

Enzyme Inhibitor ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Angiotensin Ii Receptor Antagonist

Download Full-text

Antiatherogenic effect of angiotensin converting enzyme inhibitor (benazepril) and angiotensin II receptor antagonist (valsartan) in the cholesterol-fed rabbits

Atherosclerosis ◽

10.1016/s0021-9150(98)00309-8 ◽

1999 ◽

Vol 143 (2) ◽

pp. 315-326 ◽

Author(s):

Jing Li ◽

Nobuyoshi Hirose ◽

Masahide Kawamura ◽

Yasumichi Arai

Keyword(s):

Angiotensin Ii ◽

Angiotensin Converting Enzyme ◽

Receptor Antagonist ◽

Angiotensin Converting Enzyme Inhibitor ◽

Enzyme Inhibitor ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Angiotensin Ii Receptor Antagonist ◽

Converting Enzyme Inhibitor ◽

Antiatherogenic Effect

Download Full-text

Synergistic effect on reduction in blood pressure with coadministration of a renin inhibitor or an angiotensin-converting enzyme inhibitor with an angiotensin II receptor antagonist

Drug Development Research ◽

10.1002/ddr.430330405 ◽

1994 ◽

Vol 33 (4) ◽

pp. 422-428 ◽

Author(s):

Anthony A. Fossa ◽

Michael J. Depasquale ◽

Laura J. Ringer ◽

Roxanne L. Winslow

Keyword(s):

Blood Pressure ◽

Angiotensin Ii ◽

Synergistic Effect ◽

Angiotensin Converting Enzyme ◽

Receptor Antagonist ◽

Angiotensin Converting Enzyme Inhibitor ◽

Enzyme Inhibitor ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Angiotensin Ii Receptor Antagonist

Download Full-text

Effects of chronic angiotensin II receptor antagonist and angiotensin-converting enzyme inhibitor treatments on neurohormonal levels and haemodynamics during cardiopulmonary bypass †

British Journal of Anaesthesia ◽

10.1093/bja/ael268 ◽

2006 ◽

Vol 97 (6) ◽

pp. 792-798 ◽

Author(s):

Y.J. Oh ◽

J.H. Lee ◽

S.B. Nam ◽

J.K. Shim ◽

J.H. Song ◽

...

Keyword(s):

Cardiopulmonary Bypass ◽

Angiotensin Ii ◽

Angiotensin Converting Enzyme ◽

Receptor Antagonist ◽

Angiotensin Converting Enzyme Inhibitor ◽

Enzyme Inhibitor ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Angiotensin Ii Receptor Antagonist ◽

Converting Enzyme Inhibitor

Download Full-text

Effect of angiotensin converting enzyme inhibitor and angiotensin II receptor antagonist on metabolism and contractility in ischemic and reperfused rabbit heart

Journal of Cardiac Failure ◽

10.1016/s1071-9164(99)91222-8 ◽

1999 ◽

Vol 5 (3) ◽

pp. 65

Author(s):

Hitoshi Kawabata ◽

Teruhiko Ryomoto ◽

Kinji Ishikawa

Keyword(s):

Angiotensin Ii ◽

Angiotensin Converting Enzyme ◽

Receptor Antagonist ◽

Angiotensin Converting Enzyme Inhibitor ◽

Enzyme Inhibitor ◽

Rabbit Heart ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Angiotensin Ii Receptor Antagonist ◽

Converting Enzyme Inhibitor

Download Full-text